DISCLAIMER
The information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.compose your message
message sent
email sent successfully
Trusted Resources: Community Center
Online groups, photo galleries and blogs
Co-Pay Relief Brochure
PAF’s Co-Pay Relief Program helps eligible insured individuals by offering financial assistance for co-payment, co-insurance, and deductible expenses related to pharmaceutical treatments and/or medications prescriptions relative to their diagnosis. This brochure provides eligibility criteria, application process and contact information for the program.

Related Content
-
people & placesJennifer A. Rothman, M.D.Dr. Rothman treats children with cancer ...
-
education & researchGuidelines for the use of hydroxycarbamide in children and adults with sickle cell disease: A British society for ha...Sickle cell disease (SCD) is a generic t...
-
news & eventsGBT and SCDAA Kick Off “Lift Every Voice to Shine the Light on Sickle Cell”In recognition of World Sickle Cell Day,...
-
news & eventsEx-rutgers stars Devin and Jason McCourty top $1M in fundraising for charityAbout 200 donors showed up Saturday afte...
-
education & researchDiving into the genetics of Sickle cell diseaseIn recent years, genetics has become a h...
-
videos & visualsSickle Cell Emergency Room Care: From Patients to Providershttps://www.youtube.com/watch?time_conti...
-
news & eventsGlobal Blood Therapeutics Receives EMA PRIME Designation for GBT440 for the Treatment of Sickle Cell Disease (SCD)GBT440 is First Potential Treatment for ...
send a message
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.